A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Duodenitis

NCT04856891 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

94

Enrollment

INDUSTRY

Sponsor class

Conditions

Eosinophilic Duodenitis
Eosinophilic Gastroenteritis

Interventions

DRUG: AK002
OTHER: Placebo

Sponsor

Allakos Inc.